Anna Protopapas

Insider Reports History

Entity
Individual
Location
Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, MA
Signature
/s/ Nathan N. McConarty, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anna Protopapas:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Mersana Therapeutics, Inc. Director Common Stock 125K $339K $2.71 Jan 16, 2024 Direct
Nuvalent, Inc. Director Class A Common Stock 2.5K $206K $82.33 Jun 12, 2024 Direct
Mersana Therapeutics, Inc. Director Common Stock 72.3K $196K $2.71 Jan 13, 2024 By Trust
Dicerna Pharmaceuticals Inc Director Common Stock 3.33K $127K $38.25 Jun 3, 2021 Direct
Mersana Therapeutics, Inc. Director Stock Option (right to buy) 55K Jun 11, 2024 Direct
Nuvalent, Inc. Director Stock Option (Right to Buy) 3.79K Jun 12, 2024 Direct
Dicerna Pharmaceuticals Inc Director Restricted Stock Units 0 Jun 3, 2021 Direct
Mersana Therapeutics, Inc. Director Restricted Stock Unit 0 $2.71 Jan 15, 2024 Direct

Insider Reports Filed by Anna Protopapas

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NUVL Nuvalent, Inc. Jun 12, 2024 2 $0 4 Jun 14, 2024 Director
MRSN Mersana Therapeutics, Inc. Jun 11, 2024 1 $0 4 Jun 12, 2024 Director
MRSN Mersana Therapeutics, Inc. Jan 13, 2024 9 -$79.7K 4 Jan 17, 2024 Director
NUVL Nuvalent, Inc. Dec 18, 2023 3 -$332K 4 Dec 20, 2023 Director
MRSN Mersana Therapeutics, Inc. Sep 11, 2023 2 $0 4 Sep 13, 2023 Director
NUVL Nuvalent, Inc. Jun 15, 2023 1 $0 4 Jun 16, 2023 Director
MRSN Mersana Therapeutics, Inc. Jan 13, 2023 11 -$99.6K 4 Jan 18, 2023 President & CEO, Director
NUVL Nuvalent, Inc. Jun 16, 2022 1 $0 4 Jun 17, 2022 Director
NUVL Nuvalent, Inc. Mar 30, 2022 1 $0 4 Mar 31, 2022 Director
NUVL Nuvalent, Inc. Mar 30, 2022 0 $0 3 Mar 31, 2022 Director
MRSN Mersana Therapeutics, Inc. Jan 14, 2022 5 $0 4 Jan 19, 2022 President & CEO, Director
MRSN Mersana Therapeutics, Inc. Jul 15, 2021 4 -$513K 4 Jul 19, 2021 President & CEO, Director
DRNA Dicerna Pharmaceuticals Inc Jun 3, 2021 2 $0 4 Jun 7, 2021 Director